Skip to content

New America Acquisition I NWAX Common Stock Issued In Exchange For Deferred Offering Costs

Common Stock Issued In Exchange For Deferred Offering Costs at other companies

Evommune
 logo
Evommune EVMN
$577.47K
Archer Aviation logo
Archer AviationACHR
$0-100%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$7.5M+50.0%
Evommune
 logo
Evommune EVMN
-$63K
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$0-100%
NWN
Northwest NaturalNWN
$22.26M+2,217%

Other financials

Income statement

See full
Operating income-$312.0K
Net income$2.1M
EPS (diluted)$0.04

Balance sheet

See full
Cash & equivalents$855.5K
Total equity$578.9K
Total assets$350.4M

Cash flow

See full
Operating cash flow-$88.6K

Valuation

See full
Market cap$504.43M-0.5%

Returns & leverage

See full
Current ratio1.3×

Where this comes from

Reported directly by New America Acquisition I in its filing.

Tagged under the XBRL concept NWAX:CommonStockIssuedInExchangeForDeferredOfferingCosts.

The official record: New America Acquisition I ’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about New America Acquisition I 's common stock issued in exchange for deferred offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is New America Acquisition I 's common stock issued in exchange for deferred offering costs?
New America Acquisition I (NWAX) reported common stock issued in exchange for deferred offering costs of $25K in Q4 2025.
What does common stock issued in exchange for deferred offering costs mean?
This represents the issuance of common stock as a non-cash payment to settle obligations related to offering costs. It allows the company to preserve cash liquidity by utilizing equity to cover professional and administrative fees. This metric is indicative of the company's strategy to manage cash burn through equity-based settlements.